Edesa Biotech Inc (EDSA)
4.40
0.00 (0.00%)
USD |
NASDAQ |
Apr 18, 16:00
4.40
0.00 (0.00%)
After-Hours: 19:30
Edesa Biotech Shareholders Equity (Quarterly): 5.845M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 5.845M |
September 30, 2023 | 7.049M |
June 30, 2023 | 7.850M |
March 31, 2023 | 9.000M |
December 31, 2022 | 10.27M |
September 30, 2022 | 9.391M |
June 30, 2022 | 11.84M |
March 31, 2022 | 17.02M |
December 31, 2021 | 10.55M |
September 30, 2021 | 13.06M |
June 30, 2021 | 15.80M |
March 31, 2021 | 19.27M |
December 31, 2020 | 7.885M |
September 30, 2020 | 6.631M |
June 30, 2020 | 5.342M |
March 31, 2020 | 6.931M |
December 31, 2019 | 4.234M |
June 30, 2019 | 6.213M |
March 31, 2019 | 8.270M |
December 31, 2018 | 9.908M |
September 30, 2018 | 11.29M |
June 30, 2018 | 12.39M |
March 31, 2018 | 4.74M |
December 31, 2017 | 6.019M |
September 30, 2017 | 7.399M |
Date | Value |
---|---|
June 30, 2017 | 8.597M |
March 31, 2017 | 9.790M |
December 31, 2016 | 10.86M |
September 30, 2016 | 12.31M |
June 30, 2016 | 7.661M |
March 31, 2016 | 8.813M |
December 31, 2015 | 9.631M |
September 30, 2015 | 8.005M |
June 30, 2015 | 9.433M |
March 31, 2015 | 8.923M |
December 31, 2014 | 9.237M |
August 31, 2014 | 7.701M |
May 31, 2014 | 11.15M |
February 28, 2014 | 9.131M |
November 30, 2013 | 8.405M |
August 31, 2013 | -2.196M |
May 31, 2013 | -3.117M |
February 28, 2013 | -3.196M |
November 30, 2012 | 0.6838M |
August 31, 2012 | 0.8516M |
May 31, 2012 | 2.027M |
February 29, 2012 | 2.806M |
November 30, 2011 | 3.690M |
August 31, 2011 | 3.064M |
May 31, 2011 | 5.577M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
4.234M
Minimum
Dec 2019
19.27M
Maximum
Mar 2021
9.677M
Average
8.443M
Median
Shareholders Equity (Quarterly) Benchmarks
Acasti Pharma Inc | 64.68M |
Aurinia Pharmaceuticals Inc | 377.95M |
Lexaria Bioscience Corp | 6.521M |
Xenon Pharmaceuticals Inc | 927.92M |
ESSA Pharma Inc | 140.68M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 7.832M |
Total Liabilities (Quarterly) | 1.987M |